Safe IV therapies in developing countries

Reducing mortality with an electronically controlled infusion set

Research News /

Many diseases require intravenous (IV) infusion therapy. But uncontrolled infu-sion rates and incorrect dosing can lead to severe complications or even death. The ECGF-IS project aims to improve the safety of IV therapies in developing countries. Its goal is to develop a low-cost, electronically controlled gravity-feed infusion system to reduce the mortality associated with over-infusion and under-infusion, especially in children. Fraunhofer researchers are developing the device in collaboration with the Uganda Industrial Research Institute. They have received the 2020 German-African Innovation Incentive Award (GAIIA) for their work on the project so far.